We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+21.26%
1 Year Est. Return
+80.99%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.97B
AUM Growth
+$710M
Cap. Flow
+$33.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
43.85%
Holding
701
New
35
Increased
130
Reduced
246
Closed
41

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$31M
2
BTI icon
British American Tobacco
BTI
+$29.2M
3
SAP icon
SAP
SAP
+$27.1M
4
HOOD icon
Robinhood
HOOD
+$17.9M
5
CLS icon
Celestica
CLS
+$13.7M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$29.1M
2
TSM icon
TSMC
TSM
+$26.3M
3
META icon
Meta Platforms (Facebook)
META
+$23.5M
4
BEKE icon
KE Holdings
BEKE
+$22.1M
5
TCOM icon
Trip.com Group
TCOM
+$17M

Sector Composition

Rank Sector Weight
1 Technology 46.19%
2 Consumer Discretionary 14.25%
3 Communication Services 13.85%
4 Healthcare 7.17%
5 Consumer Staples 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABUS icon
526
Arbutus Biopharma
ABUS
$871M
$15K ﹤0.01%
4,852
– –
EOLS icon
527
Evolus
EOLS
$410M
$14.9K ﹤0.01%
1,621
– –
RLAY icon
528
Relay Therapeutics
RLAY
$3.99B
$14.8K ﹤0.01%
4,286
– –
URGN icon
529
UroGen Pharma
URGN
$1.99B
$14.8K ﹤0.01%
1,080
– –
CSTL icon
530
Castle Biosciences
CSTL
$725M
$14.6K ﹤0.01%
716
– –
SAGE
531
DELISTED
Sage Therapeutics
SAGE
$14.3K ﹤0.01%
1,566
– –
KALV
532
DELISTED
KalVista Pharmaceuticals
KALV
$14.1K ﹤0.01%
1,247
– –
XNCR icon
533
Xencor
XNCR
$1.48B
$14.1K ﹤0.01%
1,791
– –
TBPH icon
534
Theravance Biopharma
TBPH
$875M
$13.9K ﹤0.01%
1,258
– –
KROS icon
535
Keros Therapeutics
KROS
$199M
$13.8K ﹤0.01%
1,036
– –
NXRT
536
NexPoint Residential Trust
NXRT
$686M
$13.8K ﹤0.01%
415
-14
-3% -$496
TNGX icon
537
Tango Therapeutics
TNGX
$4.34B
$13.6K ﹤0.01%
2,665
– –
IOVA icon
538
Iovance Biotherapeutics
IOVA
$2.1B
$13.4K ﹤0.01%
7,805
– –
PAHC icon
539
Phibro Animal Health
PAHC
$1.48B
$13.3K ﹤0.01%
520
– –
MGTX icon
540
MeiraGTx Holdings
MGTX
$1.09B
$13K ﹤0.01%
2,001
– –
ARVN icon
541
Arvinas
ARVN
$529M
$12.9K ﹤0.01%
1,759
– –
SAFE
542
Safehold
SAFE
$1.19B
$12.9K ﹤0.01%
832
-39
-4% -$606
TYRA icon
543
Tyra Biosciences
TYRA
$1.84B
$12.4K ﹤0.01%
1,296
– –
DFTX
544
Definium Therapeutics
DFTX
$5.57B
$12.2K ﹤0.01%
1,877
– –
TSHA icon
545
Taysha Gene Therapies
TSHA
$1.57B
$12.1K ﹤0.01%
5,248
– –
ZVRA icon
546
Zevra Therapeutics
ZVRA
$575M
$12K ﹤0.01%
1,367
– –
HCM icon
547
HUTCHMED
HCM
$1.93B
$11.9K ﹤0.01%
794
– –
SIGA icon
548
SIGA Technologies
SIGA
$240M
$11.9K ﹤0.01%
1,828
– –
PSNL icon
549
Personalis
PSNL
$1.27B
$11.9K ﹤0.01%
1,809
– –
EVRG icon
550
Evergy
EVRG
$19.7B
$11.8K ﹤0.01%
171
-7,469
-98% -$502K
20 21
22
23 24

Similar funds

CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
BP
BC Partners New York $5.96B AUM 15.21% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $5.94B AUM 18.44% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.03B AUM 40.55% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
AL
Appaloosa LP Short Hills, New Jersey $5.93B AUM 44.55% 1-Year Est. Return
CGPCS
Capital Group Private Client Services Los Angeles, California $5.93B AUM 27.73% 1-Year Est. Return

GF Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, GF Fund Management held 701 positions worth $4.97B, up 17% from $4.26B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

GF Fund Management's Q2 2025 filing shows 35 new, 130 increased, 246 reduced and 41 closed positions. Its largest new stake was Shopify: 120,000 shares worth $13.8M. The largest sale was NVIDIA, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 42% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q2 2025 buy was Shopify: 120,000 shares worth $13.8M.
  • GF Fund Management added most to UnitedHealth in Q2 2025, an estimated $31M increase.
  • GF Fund Management's biggest Q2 2025 reduction was NVIDIA, cutting an estimated $29.1M.
  • GF Fund Management fully exited Salesforce in Q2 2025, selling an estimated $9.77M.
  • GF Fund Management's ten largest holdings make up 44% of its $4.97B portfolio in Q2 2025.
  • GF Fund Management opened 35 new positions and closed 41 in Q2 2025.
  • GF Fund Management's portfolio value rose 17% quarter-over-quarter to $4.97B.

Based on GF Fund Management's 13F filing for Q2 2025, filed 22 Jul 2025.